Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1992 Sep 1;89(17):8351–8355. doi: 10.1073/pnas.89.17.8351

Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506.

A Karpas 1, M Lowdell 1, S K Jacobson 1, F Hill 1
PMCID: PMC49916  PMID: 1381509

Abstract

The effects of the immunosuppressive drugs cyclosporin A and FK 506 were studied on cells chronically infected with human immunodeficiency virus type 1 (HIV-1) as well as on uninfected and newly infected cells. When cells chronically infected with HIV-1 or with HIV-2 were cocultivated with uninfected cells in the presence of cyclosporin A or FK 506 there was a delay in the formation of syncytia and of cytopathic effects. This inhibitory effect was not due to decreased membrane expression of CD4. In addition, there was an approximately 100-fold reduction in the yield of infectious HIV-1 when the infected cells were grown in the presence of these drugs, a finding consistent with other evidence of decreased HIV expression. Both drugs were found to inhibit the growth of chronically infected cells at concentrations that did not inhibit the growth of the uninfected cells. These results, demonstrating that cyclosporin A and FK 506 interfere with HIV production and selectively inhibit the growth of infected cells, suggest that they may be useful in the treatment of this infection and indicate further cellular targets for antiviral agents.

Full text

PDF
8351

Images in this article

8352Image
on p.8352
8354Image
on p.8354

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrieu J. M., Even P., Venet A., Tourani J. M., Stern M., Lowenstein W., Audroin C., Eme D., Masson D., Sors H. Effects of cyclosporin on T-cell subsets in human immunodeficiency virus disease. Clin Immunol Immunopathol. 1988 May;47(2):181–198. doi: 10.1016/0090-1229(88)90071-2. [DOI] [PubMed] [Google Scholar]
  2. Bardini G., Re M. C., Rosti G., Belardinelli A. R. HIV infection and bone-marrow transplantation. Lancet. 1991 May 11;337(8750):1163–1164. doi: 10.1016/0140-6736(91)92831-l. [DOI] [PubMed] [Google Scholar]
  3. Barré-Sinoussi F., Chermann J. C., Rey F., Nugeyre M. T., Chamaret S., Gruest J., Dauguet C., Axler-Blin C., Vézinet-Brun F., Rouzioux C. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983 May 20;220(4599):868–871. doi: 10.1126/science.6189183. [DOI] [PubMed] [Google Scholar]
  4. Clavel F., Guétard D., Brun-Vézinet F., Chamaret S., Rey M. A., Santos-Ferreira M. O., Laurent A. G., Dauguet C., Katlama C., Rouzioux C. Isolation of a new human retrovirus from West African patients with AIDS. Science. 1986 Jul 18;233(4761):343–346. doi: 10.1126/science.2425430. [DOI] [PubMed] [Google Scholar]
  5. DeFranco A. L. Signal transduction. Immunosuppressants at work. Nature. 1991 Aug 29;352(6338):754–755. doi: 10.1038/352754a0. [DOI] [PubMed] [Google Scholar]
  6. Dournon E., Matheron S., Rozenbaum W., Gharakhanian S., Michon C., Girard P. M., Perronne C., Salmon D., De Truchis P., Leport C. Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex. Lancet. 1988 Dec 3;2(8623):1297–1302. doi: 10.1016/s0140-6736(88)92903-0. [DOI] [PubMed] [Google Scholar]
  7. Ellrodt A., Barre-Sinoussi F., Le Bras P., Nugeyre M. T., Palazzo L., Rey F., Brun-Vezinet F., Rouzioux C., Segond P., Caquet R. Isolation of human T-lymphotropic retrovirus (LAV) from Zairian married couple, one with AIDS, one with prodromes. Lancet. 1984 Jun 23;1(8391):1383–1385. doi: 10.1016/s0140-6736(84)91877-4. [DOI] [PubMed] [Google Scholar]
  8. Emmel E. A., Verweij C. L., Durand D. B., Higgins K. M., Lacy E., Crabtree G. R. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science. 1989 Dec 22;246(4937):1617–1620. doi: 10.1126/science.2595372. [DOI] [PubMed] [Google Scholar]
  9. Flanagan W. M., Corthésy B., Bram R. J., Crabtree G. R. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature. 1991 Aug 29;352(6338):803–807. doi: 10.1038/352803a0. [DOI] [PubMed] [Google Scholar]
  10. Gething M. J., Sambrook J. Protein folding in the cell. Nature. 1992 Jan 2;355(6355):33–45. doi: 10.1038/355033a0. [DOI] [PubMed] [Google Scholar]
  11. Glassock R. J., Cohen A. H., Danovitch G., Parsa K. P. Human immunodeficiency virus (HIV) infection and the kidney. Ann Intern Med. 1990 Jan 1;112(1):35–49. doi: 10.7326/0003-4819-112-1-35. [DOI] [PubMed] [Google Scholar]
  12. Guyader M., Emerman M., Sonigo P., Clavel F., Montagnier L., Alizon M. Genome organization and transactivation of the human immunodeficiency virus type 2. Nature. 1987 Apr 16;326(6114):662–669. doi: 10.1038/326662a0. [DOI] [PubMed] [Google Scholar]
  13. Hoxie J. A., Haggarty B. S., Rackowski J. L., Pillsbury N., Levy J. A. Persistent noncytopathic infection of normal human T lymphocytes with AIDS-associated retrovirus. Science. 1985 Sep 27;229(4720):1400–1402. doi: 10.1126/science.2994222. [DOI] [PubMed] [Google Scholar]
  14. Jacobson S. K., Calne R. Y., Wreghitt T. G. Outcome of HIV infection in transplant patient on cyclosporin. Lancet. 1991 Mar 30;337(8744):794–794. doi: 10.1016/0140-6736(91)91414-p. [DOI] [PubMed] [Google Scholar]
  15. Karpas A., Fleet G. W., Dwek R. A., Petursson S., Namgoong S. K., Ramsden N. G., Jacob G. S., Rademacher T. W. Aminosugar derivatives as potential anti-human immunodeficiency virus agents. Proc Natl Acad Sci U S A. 1988 Dec;85(23):9229–9233. doi: 10.1073/pnas.85.23.9229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Karpas A., Gillson W., Bevan P. C., Oates J. K. Lytic infection by British AIDS virus and development of rapid cell test for antiviral antibodies. Lancet. 1985 Sep 28;2(8457):695–697. doi: 10.1016/s0140-6736(85)92934-4. [DOI] [PubMed] [Google Scholar]
  17. Klatzmann D., Laporte J. P., Achour A., Brisson E., Gruest J., Montagnier L., Gluckman J. C. Inhibition fonctionnelle par la ciclosporine A du récepteur lymphocytaire du virus du sida (HIV). C R Acad Sci III. 1986;303(9):343–348. [PubMed] [Google Scholar]
  18. Larder B. A., Kemp S. D. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science. 1989 Dec 1;246(4934):1155–1158. doi: 10.1126/science.2479983. [DOI] [PubMed] [Google Scholar]
  19. Liu J., Farmer J. D., Jr, Lane W. S., Friedman J., Weissman I., Schreiber S. L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 1991 Aug 23;66(4):807–815. doi: 10.1016/0092-8674(91)90124-h. [DOI] [PubMed] [Google Scholar]
  20. Mir N., Costello C. Zidovudine and bone marrow. Lancet. 1988 Nov 19;2(8621):1195–1196. doi: 10.1016/s0140-6736(88)90262-0. [DOI] [PubMed] [Google Scholar]
  21. Phillips A., Wainberg M. A., Coates R., Klein M., Rachlis A., Read S., Shepherd F., Vellend H., Walmsley S., Halloran P. Cyclosporine-induced deterioration in patients with AIDS. CMAJ. 1989 Jun 15;140(12):1456–1460. [PMC free article] [PubMed] [Google Scholar]
  22. Poli F., Scalamogna M., Pizzi C., Mozzi F., Sirchia G. HIV infection in cadaveric renal allograft recipients in the North Italy Transplant Program. Transplantation. 1989 Apr;47(4):724–725. doi: 10.1097/00007890-198904000-00031. [DOI] [PubMed] [Google Scholar]
  23. Ragni M. V., Bontempo F. A., Lewis J. H. Organ transplantation in HIV-positive patients with hemophilia. N Engl J Med. 1990 Jun 28;322(26):1886–1887. doi: 10.1056/nejm199006283222613. [DOI] [PubMed] [Google Scholar]
  24. Schreiber S. L. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science. 1991 Jan 18;251(4991):283–287. doi: 10.1126/science.1702904. [DOI] [PubMed] [Google Scholar]
  25. Thomson A. W. FK-506--how much potential? Immunol Today. 1989 Jan;10(1):6–9. doi: 10.1016/0167-5699(89)90057-1. [DOI] [PubMed] [Google Scholar]
  26. Tristem M., Mansinho K., Champalimaud J. L., Ayres L., Karpas A. Six new isolates of human immunodeficiency virus type 2 (HIV-2) and the molecular characterization of one (HIV-2CAM2). J Gen Virol. 1989 Feb;70(Pt 2):479–484. doi: 10.1099/0022-1317-70-2-479. [DOI] [PubMed] [Google Scholar]
  27. Tzakis A. G., Cooper M. H., Dummer J. S., Ragni M., Ward J. W., Starzl T. E. Transplantation in HIV+ patients. Transplantation. 1990 Feb;49(2):354–358. doi: 10.1097/00007890-199002000-00025. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES